(Q68440881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Evidence that the substantia nigra is a site of action for L-DOPA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Evidence that the substantia nigra is a site of action for l-DOPA (English)

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

4 January 2023

author name string

G. S. Robertson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393296

4 January 2023

H. A. Robertson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3393296

4 January 2023

language of work or name

English

0 references

publication date

1 June 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

29 June 1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3393296

full work available at URL

4 January 2023

https://api.elsevier.com/content/article/PII:0304394088903825?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

https://api.elsevier.com/content/article/PII:0304394088903825?httpAccept=text/plain

4 January 2023

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

4 January 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

204-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat.

24 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats

4 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

The mechanisms of action of L-dopa in Parkinson's disease

4 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Evidence for a functional role of dopamine type-1 (D-1) receptors in the substantia nigra of rats

4 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism

4 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System

4 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro

4 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action

4 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.

4 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Pharmacologic effects of L-dopa are not closely linked temporally to striatal dopamine concentration

4 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions

4 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra

4 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

Striatal dopamine after cortical injury: a reexamination

4 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0304-3940(88)90382-5

4 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3393296%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference